GF
TAK icon

Gabelli Funds’s Takeda Pharmaceutical TAK Stock Holding History

Gabelli Funds’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-288,057
Closed -$4.72M – 1442
2021
Q3 		$4.72M Sell
288,057
-2,250
-0.8% -$37.8K 0.03% 518
2021
Q2 		$4.89M Hold
290,307
– – 0.03% 531
2021
Q1 		$5.3M Buy
290,307
+650
+0.2% +$11.7K 0.04% 485
2020
Q4 		$5.27M Sell
289,657
-60,755
-17% -$1.07M 0.04% 463
2020
Q3 		$6.25M Hold
350,412
– – 0.05% 394
2020
Q2 		$6.28M Hold
350,412
– – 0.05% 393
2020
Q1 		$5.32M Buy
350,412
+200
+0.1% +$3.63K 0.05% 402
2019
Q4 		$6.91M Buy
350,212
+1,100
+0.3% +$21K 0.04% 426
2019
Q3 		$6M Buy
349,112
+400
+0.1% +$6.92K 0.04% 459
2019
Q2 		$6.17M Buy
348,712
+1,400
+0.4% +$25.5K 0.04% 466
2019
Q1 		$7.08M Buy
+347,312
New +$6.99M 0.04% 434

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gabelli Funds's TAK Position: Q4 2021 in Review

Gabelli Funds sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 288,057 shares — an estimated $4.72M sold.

Gabelli Funds first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $7.08M in Q1 2019. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Gabelli Funds reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Gabelli Funds sold 288,057 Takeda Pharmaceutical shares in Q4 2021, an estimated $4.72M.
  • Gabelli Funds first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
  • Gabelli Funds's Takeda Pharmaceutical position peaked at $7.08M in Q1 2019.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Gabelli Funds's 13F filing for Q4 2021, filed 11 Feb 2022.